Merck (MRK) Guides Q1 Below the Street, Affirms FY12 Outlook
Tweet
Share
E-mailGet Alerts MRK Hot Sheet
Price: $152.55 +2.39%
Financial Fact:
Net Income Attributable to Merck & Co., Inc.: 7.95B
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Net Income Attributable to Merck & Co., Inc.: 7.95B
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Merck (NYSE: MRK) sees Q1 adj-EPS of 95-98 cents, which compares to the Street estimate of $1.01.
Affirms its FY12 non-GAAP EPS outlook of $3.75-$3.85.
Affirms its FY12 non-GAAP EPS outlook of $3.75-$3.85.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Upgrades Merck (MRK) to Overweight
- Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
Create E-mail Alert Related Categories
Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
